CSL Plasma Offering $40,000 for Breakthrough Ideas to Help Plasma Shortage

04/14/2021

Immunoglobulin (Ig) replacement therapy company, CSL Plasma, has sent out a challenge to help them with their plasma supply--offering $40,000 and mentorship to the person or team who can help. They are partnering with Australian start-up incubator Cicada Innovations. 

With the ongoing plasma supply shortage, which has been exacerbated by the COVID-19 pandemic, CSL Plasma wants to enhance its current processes to collect more Ig from every liter of donated plasma. 

To win, individuals or team entrants only need to have a good idea. There is no requirement for the idea to be a fully functioning product. Applications close on May 25.

Learn more about this opportunity.

Join the Plasma Hero online community

Subscribe to Plasma Hero to get important news and updates that include hero stories and ways to get involved!

Sign up

News & Updates

Get the latest information on plasma through our news and updates. Featuring: Scientific discoveries, plasma supply, industry-related coverage, policy and legislation, and more!

How to prepare for a successful plasma donation

09/10/2024

Keys to successful plasma donation include eating protein-rich foods, staying hydrated, avoiding caffeine, bringing ID and entertainment, and rest.
Read More

The mouse effect: Streaming sensation Ironmouse's journey with CVID

08/12/2024

At the 2024 PI Conference, Ironmouse was recognized by the Immune Deficiency Foundation with its Plasma Hero Award.
Read More

Those with alpha-1 antitrypsin deficiency depend on plasma donations

07/16/2024

Many rare, chronic conditions with no known cures, including alpha-1 antitrypsin deficiency, can be managed with augmentation therapy treatments made from donated plasma.
Read More

Increase plasma supply by harmonizing state regulations

06/11/2024

States with regulations exceeding FDA standards create barriers for plasma centers, donors, and patients.
Read More

Plasma is a vital weapon against tetanus and rabies

05/20/2024

While tetanus and rabies are fairly rare in the United States today, these deadly diseases still pose a major global health threat. However, plasma-derived antibody products play a crucial role in treating these illnesses around the world.
Read More

Congressional Plasma Caucus formed to address concerns of constituents

04/25/2024

Members of the congressional Plasma Caucus provide a venue to educate legislators on important legislation to provide access to patients who rely on immunoglobulin (Ig) therapy.
Read More